欧洲体外诊断市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

欧洲体外诊断市场按技术、产品(仪器、试剂和其他产品)、可用性、应用、最终用户和地理划分。

市场快照

CAGR
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 5.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期内,预计欧洲体外诊断市场的复合年增长率为 5.5%。推动市场发展的主要因素包括慢性病的快速增长、对即时检测和个性化医疗的需求增加、技术进步以及该国老年人口的增加。此外,患者可以在体外诊断设备的帮助下更好地应对自己的病情(糖尿病患者可以定期使用便携式血糖监测仪来确定他们的血糖水平)。因此,对体外诊断产品的需求受到慢性病发病率增加的影响。随着对 IVD 的需求不断增加,随着许多制造商的存在和许多国家的研究活动,预计欧洲市场将健康增长。

报告范围

IVD 是在实验室或由消费者在家中进行的测试,用于诊断、监测、筛查和评估各种疾病、状况或感染。IVD 产品是用于诊断疾病或其他状况的试剂、仪器和系统。IVD 是当前医疗保健系统的重要组成部分。它们减少了住院时间和康复的需要。

By Test Type
Clinical Chemistry
Molecular Diagnostics
Hematology
Immuno Diagnostics
Other Test Types
By Product
Instrument
Reagents
Other Products
By Usability
Disposable IVD Devices
Reusable IVD Devices
By Application
Infectious Disease
Diabetes
Cancer/Oncology
Cardiology
Autoimmune Disease
Nephrology
Other Applications
By End User
Diagnostic Laboratories
Hospitals and Clinics
Other End Users
Geography
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe

Report scope can be customized per your requirements. Click here.

主要市场趋势

预计仪器部门在预测期内将经历良好的复合年增长率

仪器部分包括单独或组合使用的仪器或设备,制造商旨在对人体样本进行体内检查,仅用于提供诊断、监测或兼容性目的的信息。IVD 仪器的示例包括凝血测试系统、尿液试纸、妊娠试验、血糖监测系统、玻片处理系统、细胞成像和分析系统,以及 IVD 测定和 PCR 测试平台,如 Abbott 的 Abbott m2000 RealTime System。IVD 仪器的主要增长动力之一是越来越多地采用多测试平台。通过使用多测试平台进行的体外诊断测试具有允许同时检测多个不同标记的额外优势。这在筛查患者体内是否存在药物时特别有利。在预测期内,对常规诊断的日益接受以及精准和个性化医疗的出现可能会推动欧洲市场仪器部分的增长。

invitroooo.png

竞争格局

由于许多市场参与者的存在,欧洲体外诊断市场在本质上是巩固的。欧洲的主要市场参与者正在关注合作伙伴关系和协议,以提高他们的市场占有率。例如,2019 年 4 月,QIAGEN 和 NeuMoDx 为欧洲临床实验室的下一代完全集成 PCR 系统扩展了检测菜单。他们还宣布推出 NeuMoDx 96 版本。主要参与者包括 Roche Diagnostics、Abbott Laboratories、Bio-Rad Laboratories Inc.、Danaher Corporation 和 Thermo Fisher Scientific Inc.,他们在该市场持有大量股份。但是,在产品创新和技术进步的帮助下,未来有可能会有新的参与者进入市场。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rapid Increase in Chronic Diseases

      2. 4.2.2 Increasing Number of Private Hospitals and Independent Testing Laboratories

      3. 4.2.3 Increasing Demand for Point-of-care Testing and Personalized Medicine

      4. 4.2.4 Technological Advancements by Medical Devices Companies

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations

      2. 4.3.2 Cumbersome Reimbursement Procedures

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Test Type

      1. 5.1.1 Clinical Chemistry

      2. 5.1.2 Molecular Diagnostics

      3. 5.1.3 Hematology

      4. 5.1.4 Immuno Diagnostics

      5. 5.1.5 Other Test Types

    2. 5.2 By Product

      1. 5.2.1 Instrument

      2. 5.2.2 Reagents

      3. 5.2.3 Other Products

    3. 5.3 By Usability

      1. 5.3.1 Disposable IVD Devices

      2. 5.3.2 Reusable IVD Devices

    4. 5.4 By Application

      1. 5.4.1 Infectious Disease

      2. 5.4.2 Diabetes

      3. 5.4.3 Cancer/Oncology

      4. 5.4.4 Cardiology

      5. 5.4.5 Autoimmune Disease

      6. 5.4.6 Nephrology

      7. 5.4.7 Other Applications

    5. 5.5 By End User

      1. 5.5.1 Diagnostic Laboratories

      2. 5.5.2 Hospitals and Clinics

      3. 5.5.3 Other End Users

    6. 5.6 Geography

      1. 5.6.1 Europe

        1. 5.6.1.1 Germany

        2. 5.6.1.2 United Kingdom

        3. 5.6.1.3 France

        4. 5.6.1.4 Italy

        5. 5.6.1.5 Spain

        6. 5.6.1.6 Rest of Europe

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 Bio-Rad Laboratories Inc.

      4. 6.1.4 Danaher Corporation (Beckman Coulter, Inc)

      5. 6.1.5 Johnson & Johnson

      6. 6.1.6 Roche Diagnostics

      7. 6.1.7 Siemens Healthcare

      8. 6.1.8 Thermo Fisher Scientific Inc.

      9. 6.1.9 Sysmex Corporation

      10. 6.1.10 QIAGEN

      11. 6.1.11 BioMerieux SA

      12. 6.1.12 Tesa SE

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Europe In-Vitro Diagnostics Market market is studied from 2018 - 2026.

The Europe In-Vitro Diagnostics Market is growing at a CAGR of 5.5% over the next 5 years.

Sysmex Corporation, QIAGEN, Tesa SE, BioMérieux SA, F. Hoffmann-La Roche Ltd are the major companies operating in Europe In-Vitro Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!